Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Interventional Cardiology

Background:

• Hybrid coronary revascularization (HCR) integrates surgical bypass grafting of the left anterior descending (LAD) artery with percutaneous coronary intervention (PCI) for other coronary vessels.
• HCR has been utilized since the late 1990s as an alternative to coronary artery bypass grafting (CABG) or multi-vessel PCI.

Purpose of the Study:

• To provide a comprehensive overview of Hybrid coronary revascularization (HCR).
• To evaluate patient selection criteria, procedural aspects, and clinical outcomes associated with HCR.
• To discuss future research directions, emphasizing the need for robust randomized trials.

Main Methods:

• Literature review synthesizing data on HCR.
• Evaluation of patient selection, procedural sequencing, surgical techniques, and anti-platelet strategies.
• Analysis of reported patient recovery, satisfaction, costs, and clinical outcomes from existing studies.

Main Results:

• HCR combines surgical and percutaneous approaches for complex coronary artery disease.
• The review covers critical aspects from patient selection to post-procedural care.
• Existing studies show varied outcomes, underscoring the need for further investigation.

Conclusions:

• HCR presents a viable option for select patients with coronary artery disease.
• Standardization of techniques and further clinical validation are essential.
• Adequately powered randomized trials are crucial to define HCR's optimal role and long-term efficacy.